Drug Shortage Report for TARO-ESOMEPRAZOLE

Last updated on 2021-01-31 History
Report ID 85326
Drug Identification Number 02423979
Brand name RAN-ESOMEPRAZOLE
Common or Proper name RAN-ESOMEPRAZOLE
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-28
Estimated end date 2020-12-30
Actual end date 2021-01-08
Shortage status Resolved
Updated date 2021-01-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v37 2021-01-31 French Compare
v36 2021-01-31 English Compare
v35 2020-12-03 French Compare
v34 2020-12-03 French Compare
v33 2020-12-03 English Compare
v32 2020-08-28 French Compare
v31 2020-08-28 English Compare
v30 2020-08-28 English Compare
v29 2020-07-03 French Compare
v28 2020-07-03 English Compare
v27 2020-06-01 French Compare
v26 2020-06-01 English Compare
v25 2020-05-01 French Compare
v24 2020-05-01 English Compare
v23 2020-04-13 French Compare
v22 2020-04-13 English Compare
v21 2020-03-30 French Compare
v20 2020-03-30 English Compare
v19 2020-02-24 French Compare
v18 2020-02-24 English Compare

Showing 1 to 20 of 37